H.R. 1210: Arthritis Prevention, Control, and Cure Act

H.R. 1210

Arthritis Prevention, Control, and Cure Act

Sponsor
Rep. Anna G. Eshoo

Date
September 29, 2010 (111th Congress, 2nd Session)

Staff Contact
Communications

Floor Situation

The House is expected to consider H.R. 1210 on the House floor on Wednesday, September 29, 2010, under a motion to suspend the rules, requiring a two-thirds majority vote for passage.  This legislation was introduced by Rep. Anna Eshoo (D-CA) on February 26, 2009.

Bill Summary

The bill would authorize the Secretary of Health and Human Services to develop and implement a National Arthritis Action Program that may include the following: (1) research, investigations, demonstrations, training, and studies relating to the control, prevention, and surveillance of arthritis and other rheumatic diseases; (2) provide additional grant support to encourage the expansion of research related to the prevention and management of arthritis at the Centers for Disease Control and Prevention (CDC); (3) national education and outreach activities for arthritis and other rheumatic diseases; (4) emphasis on prevention, early diagnosis, and appropriate management of arthritis and opportunities for effective patient self-management; and (5) grants to states or Indian tribes for comprehensive arthritis control and prevention programs and public health surveillance, prevention, and control activities related to arthritis and other rheumatic diseases.

 

The bill would authorize the Secretary to expand National Institutes of Health programs regarding research and related activities concerning various forms of juvenile arthritis and related conditions.

 

The bill also would require the Secretary to support activities that provide for an increase in institutional training grants to support pediatric rheumatology training and an expansion of public-private partnerships to promote education training and fellowship opportunities for pediatric rheumatologists.

 

Lastly, the bill would direct the Secretary to establish and carry out a pediatric rheumatology loan repayment program, as needed.

 

H.R. 1210 would authorize $14,600,000 for fiscal year 2012, $16,000,000 for fiscal year 2013, $17,700,000 for fiscal year 2014, $19,400,000 for fiscal year 2015, and $21,400,000 for fiscal year 2016 to be appropriated. 

Cost

As of publication, the Congressional Budget Office (CBO) had not released a score of H.R. 1210.